Manufacturer record
Deep Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by Deep Pharma (Gujarat) were declared Not of Standard Quality between April 2020 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 3C0635, Zinc Sulphate Dispersible Tablets IP 20 mg (exp Apr 2028). FDL, Vadodara (state lab) found it not of standard quality: Description. Listed in the September 2026 alert.
Records by type
16 records linked to Deep Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Zinc Sulphate Dispersible Tablets IP 20 mg | Batch 3C0635Mfg May 2026 · Exp Apr 2028 | DescriptionDescription | FDL, VadodaraState lab | Sep 2026 |
| Zinc Sulphate Dispersible Tablets IP 20mg | Batch 3C0152Mfg Feb 2026 · Exp Jan 2028 | DescriptionDescription | FDL, VadodaraState lab | Aug 2026 |
| Levocetirizine Dihydrochloride Syrup | Batch 1C0149Mfg Mar 2026 · Exp Feb 2028 | The sample does not conform to Manufacturers specification with respect to the test of Microbial contamination (Total aerobic viable count).Microbial limits | CDTL, MumbaiCDSCO lab | May 2026 |
| Dextromethorphan Hydrobromide Syrup IP. | Batch 1B0453Mfg Jul 2026 · Exp Jun 2027 | The sample received does not conform to I.P. 2022 with respect to the test for Microbial limit testMicrobial limits | CDTL, MumbaiCDSCO lab | Nov 2025 |
| Calcium Carbonate Tablets IP | Batch 3B1181Mfg Jun 2025 · Exp May 2027 | Dissolution (Calcium)Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Metformin Hydrochloride Tablets IP | Batch GT0712Mfg Aug 2023 · Exp Jul 2025 | DescriptionDescription | CDTL MumbaiCDSCO lab | Dec 2023 |
| Iron and Folic Acid (IFA) Tablets I.P. (Small)(Pink) | Batch 401Mfg Jan 2023 · Exp Dec 2024 | Description & Uniformity of ContentDescription | CDL KolkataCDSCO lab | Sep 2023 |
| Neomycin Sulphate Ointment USP 20 gm | Batch 23Mfg Mar 2023 · Exp Feb 2025 | Assay of NeomycinAssay | CDL KolkataCDSCO lab | Jul 2023 |
| Chlorpheniramine Maleate Tablets I.P. 4 mg | Batch 745Mfg Jul 2022 · Exp Jun 2024 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Nov 2022 |
| Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) | Batch 84Mfg Feb 2021 · Exp Jan 2023 | DescriptionDescription | CDL KolkataCDSCO lab | Sep 2021 |
| Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) | Batch 086Mfg Feb 2021 · Exp Jan 2023 | DescriptionDescription | CDL KolkataCDSCO lab | Aug 2021 |
| Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) | Batch 017Mfg Jan 2021 · Exp Dec 2022 | DescriptionDescription | CDL KolkataCDSCO lab | Aug 2021 |
| Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) | Batch 085Mfg Feb 2021 · Exp Jan 2023 | DescriptionDescription | CDL KolkataCDSCO lab | Aug 2021 |
| Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) | Batch 154Mfg Feb 2021 · Exp Jan 2023 | DescriptionDescription | CDL KolkataCDSCO lab | Aug 2021 |
| Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) | Batch 150Mfg Feb 2021 · Exp Jan 2023 | DescriptionDescription | CDL KolkataCDSCO lab | Aug 2021 |
| Povidone -Iodine Ointment U.S.P. 20 gm | Batch 005Mfg Feb 2019 · Exp Jan 2021 | Assay of Available IodineAssay | CDL KolkataCDSCO lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.